ConductScience.org, home

Paper17367263

Incidence and management of cutaneous toxicities associated with cetuximab.

Saif MW and 1 other. Expert Opin Drug Saf, 2007. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Incidence and management of cutaneous toxicities associated with cetuximab. Papers, record 17367263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17367263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence and management of cutaneous toxicities associated with cetuximab.
PubMed
Journal
Expert Opin Drug Saf
PubMed
Year
2007
PubMed
Publication types
Journal Article, Practice Guideline, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2019-11-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Saif MWM Wasif
2Kim RRichard

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Antineoplastic Agents, PhytogenicMajor topic
ExanthemaMajor topic
Animals
Antibodies, Monoclonal, Humanized
Cetuximab
Colorectal Neoplasms
Humans
Incidence

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42358356Pharmacovigilance analysis of cutaneous adverse drug reactions for cetuximab, panitumumab, and necitumumab based on EudraVigilance and WHO VigiAccess.Front Pharmacol2026https://conductscience.org/library/papers/42358356PubMed
40672372Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma.Front Pharmacol2025https://conductscience.org/library/papers/40672372PubMed
39618678Cetuximab-Induced Pneumonitis: An Overlooked Complication.Cureus2024https://conductscience.org/library/papers/39618678PubMed
25621507Improving target cell specificity using a novel monovalent bispecific IgG design.MAbs2015https://conductscience.org/library/papers/25621507PubMed
24371405Cetuximab related eyelash elongations for patients with metastatic rectum carcinoma: metabolic complete response.Ann Dermatol2013https://conductscience.org/library/papers/24371405PubMed
23801914A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis.Radiol Oncol2013https://conductscience.org/library/papers/23801914PubMed
21707979Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.J Med Case Rep2011https://conductscience.org/library/papers/21707979PubMed
20883055Cetuximab: a review of its use in squamous cell carcinoma of the head and neck.Drugs2010https://conductscience.org/library/papers/20883055PubMed
20616912Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.Onco Targets Ther2009https://conductscience.org/library/papers/20616912PubMed
20046573Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin.MAbs2009https://conductscience.org/library/papers/20046573PubMed
19682368Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review.J Exp Clin Cancer Res2009https://conductscience.org/library/papers/19682368PubMed
18377777Cutaneous adverse reactions to therapeutic monoclonal antibodies for cancer.Curr Allergy Asthma Rep2008https://conductscience.org/library/papers/18377777PubMed
18034592Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer.Drugs2007https://conductscience.org/library/papers/18034592PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17367263

GET https://conductscience.org/api/papers/v1/17367263/authors